Low dose of hydroxyethyl starch impairs clot formation as assessed by viscoelastic devices

References

• Reinhart K, Perner A, Sprung CL, Jaeschke R, Schortgen F, Johan Groeneveld AB, Beale R, Hartog CS. Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med 2012;38:368–83.
   PubMed Web of Science ®Google Scholar
• Patel A, Waheed U, Brett SJ. Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis. Intensive Care Med 2013;39:811–22.
   PubMed Web of Science ®Google Scholar
• Gattas DJ, Dan A, Myburgh J, Billot L, Lo S, Finfer S, Committee CM. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med 2013;39:558–68.
   PubMedGoogle Scholar
• Zarychanski R, Abou-Setta AM, Turgeon AF, Houston BL, McIntyre L, Marshall JC, Fergusson DA. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 2013;309:678–88.
   PubMed Web of Science ®Google Scholar
• Navickis RJ, Haynes GR, Wilkes MM. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials. J Thorac Cardiovasc Surg 2012;144:223–30.
   PubMed Web of Science ®Google Scholar
• Hartog CS, Reuter D, Loesche W, Hofmann M, Reinhart K. Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review. Intensive Care Med 2011;37:1725–37.
   PubMed Web of Science ®Google Scholar
• Wise J. Boldt: the great pretender. BMJ 2013;346:f1738.
   Google Scholar
• Reinhart K, Takala J. Hydroxyethyl starches: what do we still know?Anesth Analg 2011;112:507–11.
   Google Scholar
• Tynngard N, Lindahl T, Ramstrom S, Berlin G. Effects of different blood components on clot retraction analysed by measuring elasticity with a free oscillating rheometer. Platelets 2006;17:545–54.
   PubMed Web of Science ®Google Scholar
• Lindahl TL, Ramstrom S. Methods for evaluation of platelet function. Transfus Apher Sci 2009;41:121–5.
   PubMed Web of Science ®Google Scholar
• Solbeck S, Windelov NA, Baek NH, Nielsen JD, Ostrowski SR, Johansson PI. In-vitro comparison of free oscillation rheometry (ReoRox) and rotational thromboelastometry (ROTEM) in trauma patients upon hospital admission. Blood Coagul Fibrinolysis 2012;23:688–92.
   PubMed Web of Science ®Google Scholar
• Cammerer U, Dietrich W, Rampf T, Braun SL, Richter JA. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 2003;96:51–7.
   PubMed Web of Science ®Google Scholar
• Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005;27:81–90.
   PubMedGoogle Scholar
• Moretti EW, Robertson KM, El-Moalem H, Gan TJ. Intraoperative colloid administration reduces postoperative nausea and vomiting and improves postoperative outcomes compared with crystalloid administration. Anesth Analg 2003;96:611–7.
   PubMed Web of Science ®Google Scholar
• Feldheiser A, Pavlova V, Bonomo T, Jones A, Fotopoulou C, Sehouli J, Wernecke KD, Spies C. Balanced crystalloid compared with balanced colloid solution using a goal-directed haemodynamic algorithm. Br J Anaesth 2013;110:231–40.
   PubMed Web of Science ®Google Scholar
• Kozek-Langenecker SA. Influence of fluid therapy on the haemostatic system of intensive care patients. Best Pract Res Clin Anaesthesiol 2009;23:225–36.
   PubMedGoogle Scholar
• Weiss G, Lison S, Spannagl M, Heindl B. Expressiveness of global coagulation parameters in dilutional coagulopathy. Br J Anaesth 2010;105:429–36.
   PubMed Web of Science ®Google Scholar
• Sossdorf M, Marx S, Schaarschmidt B, Otto GP, Claus RA, Reinhart K, Hartog CS, Losche W. HES 130/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function. Crit Care 2009;13:R208.
   PubMed Web of Science ®Google Scholar
• Niemi TT, Kuitunen AH. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiol Scand 2005;49:373–8.
   Google Scholar
• Brinkman AC, Romijn JW, van Barneveld LJ, Greuters S, Veerhoek D, Vonk AB, Boer C. Profound effects of cardiopulmonary bypass priming solutions on the fibrin part of clot formation: an ex vivo evaluation using rotation thromboelastometry. J Cardiothorac Vasc Anesth 2010;24:422–6.
   Google Scholar
• Choi YS, Shim JK, Hong SW, Kim JC, Kwak YL. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. Minerva Anestesiol 2010;76:584–91.
   PubMed Web of Science ®Google Scholar
• Haas T, Preinreich A, Oswald E, Pajk W, Berger J, Kuehbacher G, Innerhofer P. Effects of albumin 5% and artificial colloids on clot formation in small infants. Anaesthesia 2007;62:1000–7.
   Google Scholar
• Schramko AA, Suojaranta-Ylinen RT, Kuitunen AH, Kukkonen SI, Niemi TT. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Anesth Analg 2009;108: 30–6.
   PubMed Web of Science ®Google Scholar
• Hanke AA, Maschler S, Schochl H, Floricke F, Gorlinger K, Zanger K, Kienbaum P. In vitro impairment of whole blood coagulation and platelet function by hypertonic saline hydroxyethyl starch. Scand J Trauma Resusc Emerg Med 2011;19:12.
   PubMed Web of Science ®Google Scholar
• Godier A, Durand M, Smadja D, Jeandel T, Emmerich J, Samama CM. Maize- or potato-derived hydroxyethyl starches: is there any thromboelastometric difference?Acta Anaesthesiol Scand 2010;54:1241–7.
   PubMed Web of Science ®Google Scholar
• Fenger-Eriksen C, Tonnesen E, Ingerslev J, Sorensen B. Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy. J Thromb Haemost 2009;7:1099–105.
   PubMed Web of Science ®Google Scholar
• Nielsen VG. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiol Scand 2005;49:1163–71.
   PubMed Web of Science ®Google Scholar
• De Lorenzo C, Calatzis A, Welsch U, Heindl B. Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%. Anesth Analg 2006;102:1194–200.
   PubMed Web of Science ®Google Scholar
• Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A, Innerhofer P. Effects of colloid and crystalloid solutions on endogenous activation of fibrinolysis and resistance of polymerized fibrin to recombinant tissue plasminogen activator added ex vivo. Br J Anaesth 2008;100: 307–14.
   Google Scholar
• Deusch E, Gamsjager T, Kress HG, Kozek-Langenecker SA. Binding of hydroxyethyl starch molecules to the platelet surface. Anesth Analg 2003;97:680–3.
   Google Scholar
• Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005;103:654–60.
   Google Scholar
• Johansson PI, Ostrowski SR, Secher NH. Management of major blood loss: an update. Acta Anaesthesiol Scand 2010;54:1039–49.
   PubMed Web of Science ®Google Scholar
• Reikvam H, Steien E, Hauge B, Liseth K, Hagen KG, Storkson R, Hervig T. Thrombelastography. Transfus Apher Sci 2009;40:119–23.
   PubMed Web of Science ®Google Scholar
• Bolliger D, Seeberger MD, Tanaka KA. Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfus Med Rev 2012;26:1–13.
   PubMed Web of Science ®Google Scholar
• Rasmussen KC, Johansson PI, Hojskov M, Kridina I, Kistorp T, Thind P, Nielsen HB, Ruhnau B, Pedersen T, Secher NH. Hydroxyethyl starch reduces coagulation competence and increases blood loss during major surgery: results from a randomized controlled trial. Ann Surg 2014;259:249–54.
   Google Scholar